| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.228 | 2.686 | 5.598 | 4.458 | 0 | 0 | 598 | 0 | 0 | 0 |
| Total Income - EUR | 3.228 | 2.686 | 5.598 | 4.458 | 0 | 0 | 598 | 0 | 0 | 0 |
| Total Expenses - EUR | 4.612 | 1.417 | 2.070 | 824 | 509 | 84 | 539 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | -1.384 | 1.269 | 3.527 | 3.634 | -509 | -84 | 60 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | -1.481 | 1.189 | 3.359 | 3.501 | -509 | -84 | 42 | 0 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Util Pharm Product Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 2.929 | 2.757 | 6.690 | 9.523 | 5.458 | 5.048 | 4.996 | 5.011 | 4.996 | 4.968 |
| Inventories | 92 | 92 | 90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.824 | 1.925 | 5.266 | 3.700 | 3.166 | 2.160 | 2.112 | 2.119 | 2.113 | 2.101 |
| Cash | 13 | 740 | 1.334 | 5.822 | 2.291 | 2.887 | 2.883 | 2.892 | 2.883 | 2.867 |
| Shareholders Funds | -2.422 | -1.209 | 2.170 | 5.631 | 5.013 | 4.835 | 4.769 | 4.784 | 4.769 | 4.743 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 5.352 | 3.966 | 4.520 | 3.891 | 445 | 213 | 226 | 227 | 226 | 225 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Util Pharm Product Srl